UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
001-40313
Commission File Number
BIG SKY GROWTH PARTNERS, INC.
(Exact name of registrant as specified in its charter)
1201 Western Avenue, Suite 406
Seattle, WA 98101
(406) 351-0820
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable Warrant to
acquire one share of Class A common stock
Class A common stock, par value $0.0001 per share
Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise
price of $11.50
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | ☒ | |
Rule 12g-4(a)(2) | ☐ | |
Rule 12h-3(b)(1)(i) | ☒ | |
Rule 12h-3(b)(1)(ii) | ☐ | |
Rule 15d-6 | ☐ | |
Rule 15d-22(b) | ☐ |
Units, each consisting of one share of Class A common stock, and one-fourth of one redeemable Warrant to acquire one share of Class A common stock: 0 holders
Class A Common Stock, par value $0.0001 per share: 0 holders
Redeemable Warrants each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50: 0 holders
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Pursuant to the requirements of the Securities Exchange Act of 1934, Revolution Healthcare Acquisition Corp. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: December 22, 2022 | By: | /s/ Lauren Neiswender | ||||
| Name: | Lauren Neiswender | |||||
| Title: | Chief Financial Officer |
